8
Oct
2024

SICHUAN UNIWELL BIOTECHNOLOGY CO.,LTD

Exhibitor at CPHI Milan 2024 stand 10B113, Natural Extracts
  • CN
  • 2023
    On CPHI since
Contact info
  • NO.5, BINJIANG ROAD, , QIONGLAI, 611530, Chengdu, Sichuan, China
Event information
CPHI Milan 2024
  • 08 Oct 2024 - 10 Oct 2024
  • Fiera Milano, Italy
  • Visit us at stand 10B113, Natural Extracts

Products Featured at CPHI Milan 2024

  • Andrographolide/ANDROGRAPHIS PANICULATA EXTRACT

    Product Andrographolide/ANDROGRAPHIS PANICULATA EXTRACT

    The Andrographolide is derived from the whole herb of the Acanthaceae herbaceous plant Andrographis paniculata. It is mainly containing lactones and flavonoids. The lactone components mainly include Andrographis paniculata, neo-andrographis paniculata, deoxy-andrographolide, dehydrated Andrographis p...
  • Resveratrol/POLYGONUM CUSPIDATUM EXTRACT

    Product Resveratrol/POLYGONUM CUSPIDATUM EXTRACT

    Polygonum cuspidatum extract is a plant extract derived from the root and rhizome of Polygonum cuspidatum, a perennial herb native to East Asia. Polygonum cuspidatum extract contains various bioactive compounds, such as resveratrol, emodin, polydatin, and anthraquinones. Polygonum cuspidatum extract ...
  • Retatrutide

    Product Retatrutide

    Retatrutide is a triple agonist peptide of glucagon receptor (GCGR), glucose-dependent insulin-stimulating polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor (GLP-1R). Retatrutide treats obesity in adults with significant weight loss.
    Products are for scientific use only !
  • Soy Isoflavones/SOYBEAN EXTRACT

    Product Soy Isoflavones/SOYBEAN EXTRACT

    Soy isoflavones are naturally occurring compounds found in soybeans and other soy products. They belong to a class of phytochemicals known as phytoestrogens, which are plant-derived compounds with estrogen-like activity.
  • Tirzepatide

    Product Tirzepatide

    Tirzepatide is a new type of GIP/GLP-1 receptor double agonist with potent glucose control and weight loss effects. It was approved by the US FDA in May 2022 as an adjoint therapy with diet and exercise to improve blood glucose control in adults with type 2 diabetes.Products are for scientific use onl...